Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients-Reference-Cited by-同舟云学术

Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients

Published:2012-01-09 Issue:5 Volume:32 Page:859-866
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Lee Yen-Chieh¹,Chang Chia-Hsuin,Lin Jou-Wei,Chen Hsi-Chieh²,Lin Min-Shung¹,Lai Mei-Shu²

Affiliation:

1. Department of Family Medicine; Cathay General Hospital; Taipei; Taiwan

2. Institute of Preventive Medicine; College of Public Health; National Taiwan University; Taipei; Taiwan

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2011.02739.x/fullpdf

Reference29 articles.

1. Acute upper gastrointestinal bleeding in patients with liver cirrhosis and in noncirrhotic patients: epidemiology and predictive factors of mortality in a prospective multicenter population-based study;Lecleire;J Clin Gastroenterol,2005

2. Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis;del Olmo;J Hepatol,2000

3. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators;D'Amico;Hepatology,2003

4. Development and validation of a prognostic index predicting death after upper gastrointestinal bleeding in patients with liver cirrhosis: a multicenter study;Gatta;Am J Gastroenterol,1994

5. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs;El-Serag;Am J Gastroenterol,2000

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opioid use and risks in candidates and recipients of liver transplant;Liver Transplantation;2024-04-29

2. Aspirin and NSAIDs are associated with reduced cancer and mortality risk in patients with chronic liver diseases – a Swedish cohort study;2024-03-11

3. The Safe Use of Analgesics in Patients with Cirrhosis: A Narrative Review;The American Journal of Medicine;2024-02

4. The transcriptomic profile shows the protective effects of celecoxib on cirrhotic splenomegaly;Immunopharmacology and Immunotoxicology;2023-12-04

5. Changing Prevalence of Medication Use in People with Cirrhosis: A Retrospective Cohort Study Using Pharmaceutical Benefits Scheme Data;Drugs - Real World Outcomes;2023-10-13